Effects of prolonging adjuvant aromatase inhibitor therapy beyond five years on recurrence and cause-specific mortality: An EBCTCG meta-analysis of individual patient data from 12 randomised trials including 24912 women - Early Breast Cancer Trialistsʼ Collaborative Group (San Antonio Breast Cancer Symposium, 2018)
Abstr. GS3-03